Vorinostat Terminated Phase 2 Trials for Brain Metastasis Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01600742Vorinostat and Concurrent Whole Brain Radiotherapy for Brain Metastasis